BCM
BSX icon

Bancreek Capital Management’s Boston Scientific BSX Stock Holding History

Bancreek Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,000
Closed -$2.45M – 17
2026
Q1 		$2.45M Buy
+39,000
New +$3.12M 10.59% 6

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bancreek Capital Management's BSX Position: Q2 2026 in Review

Bancreek Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 39,000 shares — an estimated $2.45M sold.

Bancreek Capital Management first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $2.45M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bancreek Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Bancreek Capital Management sold 39,000 Boston Scientific shares in Q2 2026, an estimated $2.45M.
  • Bancreek Capital Management first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
  • Bancreek Capital Management's Boston Scientific position peaked at $2.45M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bancreek Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.